Research Topics

Franz Schaefer

Summary

Affiliation: University of Heidelberg
Country: Germany

Publications

  1. Licht C, Ardissino G, Ariceta G, Cohen D, Cole J, Gasteyger C, et al. The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol. 2015;16:207 pubmed publisher
    ..US National Institutes of Health www.ClinicalTrials.gov Identifier NCT01522183 . Registered January 18, 2012. ..
  2. Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, et al. Cardiovascular Phenotypes in Children with CKD: The 4C Study. Clin J Am Soc Nephrol. 2017;12:19-28 pubmed publisher
    ..The baseline data of this large pediatric cohort show that surrogate markers for cardiovascular disease are closely associated with systolic hypertension and stage of CKD. ..
  3. Lochmüller H, Badowska D, Thompson R, Knoers N, Aartsma Rus A, Gut I, et al. RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases. Eur J Hum Genet. 2018;: pubmed publisher
    ....
  4. Schaefer F, Litwin M, Zachwieja J, Zurowska A, Turi S, Grosso A, et al. Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens. 2011;29:2484-90 pubmed publisher
    ..Valsartan and enalapril provided comparable BP reductions and effective BP control and were well tolerated in hypertensive children aged 6-17 years. ..
  5. Trautmann A, Schnaidt S, Lipska Ziętkiewicz B, Bodria M, Ozaltin F, Emma F, et al. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. J Am Soc Nephrol. 2017;28:3055-3065 pubmed publisher
    ..Children with multidrug-resistant sporadic disease show better renal survival than those with genetic disease. Furthermore, histopathologic findings may retain prognostic relevance when a genetic diagnosis is established. ..

Locale

Detail Information

Publications5

  1. Licht C, Ardissino G, Ariceta G, Cohen D, Cole J, Gasteyger C, et al. The global aHUS registry: methodology and initial patient characteristics. BMC Nephrol. 2015;16:207 pubmed publisher
    ..US National Institutes of Health www.ClinicalTrials.gov Identifier NCT01522183 . Registered January 18, 2012. ..
  2. Schaefer F, Doyon A, Azukaitis K, Bayazit A, Canpolat N, Duzova A, et al. Cardiovascular Phenotypes in Children with CKD: The 4C Study. Clin J Am Soc Nephrol. 2017;12:19-28 pubmed publisher
    ..The baseline data of this large pediatric cohort show that surrogate markers for cardiovascular disease are closely associated with systolic hypertension and stage of CKD. ..
  3. Lochmüller H, Badowska D, Thompson R, Knoers N, Aartsma Rus A, Gut I, et al. RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases. Eur J Hum Genet. 2018;: pubmed publisher
    ....
  4. Schaefer F, Litwin M, Zachwieja J, Zurowska A, Turi S, Grosso A, et al. Efficacy and safety of valsartan compared to enalapril in hypertensive children: a 12-week, randomized, double-blind, parallel-group study. J Hypertens. 2011;29:2484-90 pubmed publisher
    ..Valsartan and enalapril provided comparable BP reductions and effective BP control and were well tolerated in hypertensive children aged 6-17 years. ..
  5. Trautmann A, Schnaidt S, Lipska Ziętkiewicz B, Bodria M, Ozaltin F, Emma F, et al. Long-Term Outcome of Steroid-Resistant Nephrotic Syndrome in Children. J Am Soc Nephrol. 2017;28:3055-3065 pubmed publisher
    ..Children with multidrug-resistant sporadic disease show better renal survival than those with genetic disease. Furthermore, histopathologic findings may retain prognostic relevance when a genetic diagnosis is established. ..